ADVANCED DRUG DELIVERY SYSTEMS MARKET ANALYSIS

Advanced Drug Delivery Systems Market, By Type (Oral Drug Delivery System, Injection-Based Drug Delivery System, Inhalation/Pulmonary Drug Delivery System, Transdermal Drug Delivery System, Carrier Based Drug Delivery System, and Others), By Application (Cardiovascular Diseases, Oncology, Urology, Ophthalmology, Inflammatory Diseases, and Others), By Carrier Type (Liposomes, Nanoparticles, Microspheres, and Monoclonal Antibodies), By End User (Hospitals, Specialty Clinics, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Nov 2024
Code : CMI5243
Pages :172
Formats :
Excel and PDF
Industry : Medical Devices

Key Takeaways from Analyst

Various novel mechanisms for targeted and controlled drug release are being researched which is expected to drive market growth. biodegradable polymers have shown promise for sustained release of drugs and their use in drug-eluting stents and implants is increasing.

North America currently dominates due to the presence of major players and growing funding for R&D. Asia Pacific is anticipated to be the fastest growing region backed by expanding healthcare infrastructure and increasing expenditure on chronic disease management.

High costs of development and regulatory approvals continue to restrain market potential. Nonetheless, with numerous large molecules entering the pipeline, advanced drug delivery solutions are indispensable. Oral formulations that enable intestinal absorption of such molecules offer lucrative prospects. Further, multi-disciplinary collaborations between drug makers, material scientists and device engineers will be critical to develop next-gen formulations.